Natalie Walker | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Natalie Walker

National Institute for Health Innovation, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand


Natalie Walker is a versatile author and has contributed major research works in the field of Addiction Research and Therapy, psychology, and neurology. And has dedicated their major research contributions in the field of Addiction research, Substance-Related Disorders, Psychology, Neurology, Behavioural Science, etc.

The Effect of Varenicline Administration on Cannabis and Tobacco Use in Cannabis and Nicotine Dependent Individuals – A Case-Series

Introduction: Cannabis users may also use tobacco products which increases the potential for drug-induced harm over and above that caused by one substance on its own. Therefore, a pharmacotherapy that treats dependence on both substances would be beneficial. Tetrahydrocannabinol and varenicline act at the α7 subtype of the nicotinic receptor a... Read More»

David A L Newcombe, Natalie Walker, Janie Sheridan and Susanna Galea

Case Report: J Addict Res Ther 2015, 6:222

DOI: 10.4172/2155-6105.1000222

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article